newsfilter
← Latest News
GlobeNewswire·

Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting

- Poster presentations on BMB-101 will focus on 5-HT2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ:DRUG), a pioneering company